According to molecular characteristics of HER-2, estrogen receptor (ER), ki-67, and progesterone receptor (PR), BC can be divided into diverse subtypes, such as HER-2 overexpression, Lumina A, Lumina B, ‘normal-like’ breast tumors and basal-like tumors. This evidence concerns the gene PGR and breast cancer.